Opioid-induced bowel dysfunction pivotal assessment of lubiprostone (OPAL)

02/11/2008

Arizona, Arkansas, California, Colorado, Florida, Illinois, Indiana, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia, Canada. www.clinicaltrials.gov.

Published in Brief:

SmartBrief Job Listings for Health Care